Login Registration

Swixx Hematology Oncology Hub

EMA links

  1. Avapritinib
  2. Azacitidine
  3. Crisantaspase
  4. Daunorubicin + Cytarabine (liposomal)
  5. Defibrotide
  6. Fedratinib
  7. Ipilimumab
  8. Isatuximab
  9. Luspatercept
  10. Mogamulizumab
  11. Nivolumab
  12. Pemigatinib
  13. Relatlimab + Nivolumab
  14. Retifanlimab
  15. Tafasitamab
  16. Zanubrutinib
  • Contact us
  • Privacy Notice
  • Privacy Notice - Pharmacovigilance, Medical Information Request, Quality Complaints
  • Cookie Policy
  • Terms of Use
  • References
Swixx BioPharma

Copyright © 2026 All rights reserved.

For more information about Swixx BioPharma, please visit www.swixxbiopharma.com.

For any information about products, medical inquiries or adverse event reporting please contact medinfo in your county.

List of contacts is available at https://www.swixxbiopharma.com/en/countries/.

PM-CH-2026-3-1545
Approval date: 28.08.2026.
For HCPs only